Toxicities and Outcomes in the First Year after Ex-Vivo CD34+Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

被引:0
|
作者
Kosuri, Satyajit [1 ]
Herrera, Diego A. Adrianzen [2 ]
Scordo, Michael [1 ]
Shah, Gunjan L. [1 ]
Devlin, Sean M. [3 ]
Maloy, Molly [1 ]
Nieves, Jimmy [4 ]
Cho, Christina [1 ]
Borrill, Taylor [1 ]
Carlow, Dean [5 ]
Avecilla, Scott T. [5 ]
Meagher, Richard [5 ]
O'Reilly, Richard J. [6 ]
Koehne, Guenther [1 ]
Gyurkocza, Boglarka [1 ]
Shaffer, Brian [1 ]
Castro-Malaspina, Hugo [1 ]
Tamari, Roni [1 ]
Giralt, Sergio A. [1 ]
Perales, Miguel-Angel [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA
[2] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med Oncol, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Nursing, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant Serv, Dept Pediat, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1016/j.bbmt.2016.12.196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
391
引用
收藏
页码:S286 / S287
页数:2
相关论文
共 50 条
  • [1] The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
    Kosuri, Satyajit
    Herrera, Diego Adrianzen
    Scordo, Michael
    Shah, Gunjan L.
    Cho, Christina
    Devlin, Sean M.
    Maloy, Molly A.
    Nieves, Jimmy
    Borrill, Taylor
    Carlow, Dean C.
    Avecilla, Scott T.
    Meagher, Richard C.
    O'Reilly, Richard J.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Koehne, Guenther
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Shaffer, Brian C.
    Tamari, Roni
    Giralt, Sergio A.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 2004 - 2011
  • [2] Acute Toxicities In Patients Receiving Ex-Vivo CD34+Selected Allogeneic Stem Cell Transplantation For Hematologic Malignancies
    Herrera, D.
    Perales, M. A.
    Shah, G.
    Scordo, M.
    Devlin, S.
    Maloy, M.
    Nieves, J.
    Avecilla, S.
    Meagher, R.
    Gyurkocza, B.
    Castro-Malaspina, H.
    Shaffer, B.
    Tamari, R.
    Giralt, S.
    Kosuri, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S219 - S219
  • [3] An Analysis of Early Toxicities, Associated Risk Factors and Survival during the First Year in Adults Undergoing Ex-Vivo CD34+Selected Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
    Kosuri, Satyajit
    Herrera, Diego Adrianzen
    Scordo, Michael
    Shah, Gunjan
    Maloy, Molly A.
    Devlin, Sean
    Nieves, Jimmy
    Borrill, Taylor
    Avecilla, Scott T.
    Meagher, Richard C.
    O'Reilly, Richard J.
    Koehne, Guenther
    Shaffer, Brian C.
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo R.
    Tamari, Roni
    Giralt, Sergio A.
    Perales, Miguel
    BLOOD, 2016, 128 (22)
  • [4] Post-Transplant Toxicities and Outcomes in Long-Term Survivors of Ex-Vivo CD34+Selected Allogeneic Hematopoietic Cell Transplantation
    Scordo, Michael
    Shah, Gunjan L.
    Kosuri, Satyajit
    Herrera, Diego Adrianzen
    Cho, Christina
    Devlin, Sean M.
    Maloy, Molly
    Nieves, Jimmy
    Borrill, Taylor
    Carlow, Dean
    Avecilla, Scott T.
    Meagher, Richard
    O'Reilly, Richard J.
    Koehne, Guenther
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Tamari, Roni
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Shaffer, Brian
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S199 - S201
  • [5] Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation
    Scordo, Michael
    Shah, Gunjan L.
    Kosuri, Satyajit
    Herrera, Diego Adrianzen
    Cho, Christina
    Devlin, Sean M.
    Maloy, Molly A.
    Nieves, Jimmy
    Borrill, Taylor
    Avecilla, Scott T.
    Meagher, Richard C.
    Carlow, Dean C.
    O'Reilly, Richard J.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Koehne, Guenther
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Tamari, Roni
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Shaffer, Brian C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 133 - 141
  • [6] Immune-Mediated Hemolytic Anemia (IMHA) and Immune Thrombocytopenia (ITP) after Ex-Vivo CD34+Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Scordo, Michael
    Shah, Gunjan L.
    Kosuri, Satyajit
    Herrera, Diego A. Adrianzen
    Hsu, Meier
    Devlin, Sean M.
    Maloy, Molly
    Nieves, Jimmy
    Borrill, Taylor
    Avecilla, Scott T.
    Meagher, Richard
    O'Reilly, Richard J.
    Koehne, Guenther
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Tamari, Roni
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Shaffer, Brian
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S124 - S125
  • [7] The Impact of Individual Co-Morbidities in Myeloablative Ex Vivo CD34+Selected Allogeneic Hematopoietic Cell Transplantation
    Shouval, Roni
    Fein, Joshua A.
    Devlin, Sean M.
    Maloy, Molly A.
    Flores, Nerea Castillo
    Lin, Richard J.
    Politikos, Loannis
    Sanchez, Miriam
    Scordo, Michael
    Shah, Gunjan L.
    Barker, Juliet N.
    Giralt, Sergio A.
    Gyurkocza, Boglarka
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    O'Reilly, Richard J.
    Ponce, Doris M.
    Shaffer, Brian C.
    Sauter, Craig S.
    Tamari, Roni
    Young, Jim
    Cho, Christina
    Perales, Miguel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S141 - S141
  • [8] Outcomes after Second Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
    Huselton, Eric
    Slade, Michael
    Abboud, Camille
    Cashen, Amanda
    DiPersio, John F.
    Ghobadi, Armin
    Pusic, Iskra
    Romee, Rizwan
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S278 - S278
  • [9] Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation
    Scordo, Michael
    Hsu, Meier
    Jakubowski, Ann A.
    Shah, Gunjan L.
    Cho, Christina
    Maloy, Molly A.
    Avecilla, Scott T.
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Tamari, Roni
    O'Reilly, Richard J.
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Shaffer, Brian C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1136 - 1141
  • [10] Rituximab Use, Immune Reconstitution, and Vaccination after Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)
    Preston, Elaina V.
    Malard, Florent
    Seier, Kenneth
    Cho, Christina
    Devlin, Sean M.
    Maloy, Molly
    Borrill, Taylor
    Palazzo, Meighan
    Smith, Katherine
    Maslak, Peter
    van den Brink, Marcel R. M.
    Shah, Gunjan L.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S360 - S361